Stay updated on Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial page.

Latest updates to the Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe study history shows an added site revision entry (v3.4.2) and the removal of an older funding/operating status notice (v3.4.1). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check27 days agoChange DetectedThe page adds a site-wide funding notice and records a new revision (v3.4.1) with a Study Status entry, while removing the prior revision (v3.4.0).SummaryDifference0.7%

- Check34 days agoChange DetectedUI changes on the Study Record History page introduce a glossary, color-coded highlights (green for additions, red for deletions), and the revision label Revision: v3.4.0, while removing the No FEAR Act data note and the older Revision: v3.3.4 label.SummaryDifference0.6%

- Check48 days agoChange DetectedThe page history shows a new revision v3.3.4 has been added and the previous revision v3.3.3 is removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check70 days agoChange DetectedThe page footer now shows Revision: v3.3.3, and references to HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedLatest version entries in the Record History (around 2025-11-28 and 2025-12-05) include updates to the Study Status section for NCT03459846.SummaryDifference0.3%

Stay in the know with updates to Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial page.